Denali Therapeutics Inc. (DNLI)
Nasdaq: DNLI · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2017
Who runs Denali Therapeutics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Watts Ryan J.
President and CEO. First filing Dec 2017, latest Aug 14, 2026, 51 filings in all.
Officers reporting now
5
of 17 people with a filing in the last fifteen months
Directors reporting now
12
22 people on the record since 2017
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chin Peter Scott | Chief Medical Officer | Apr 2026 | Sep 9, 2026 | 1 · $0.00 |
| Schuth Alexander O. | COFO and Secretary | Dec 2017 | Sep 3, 2026 | 3 · $400,000 |
| Watts Ryan J. | President and CEO | Dec 2017 | Aug 14, 2026 | 1 · $600,000 |
| Krognes Steve E. | CFO and Treasurer | Dec 2017 | Jun 5, 2026 | none |
| Ho Carole | Chief Medical Officer | Dec 2017 | Aug 14, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Thornberry Nancy | director | Jan 2021 | Sep 4, 2026 | 2 · $300,000 |
| 667, L.P. | director | Jun 2025 | Jun 5, 2026 | none |
| Baker Bros. Advisors (Gp) LLC | director | Jun 2025 | Jun 5, 2026 | none |
| Baker Bros. Advisors LP | director | Jun 2025 | Jun 5, 2026 | none |
| Baker Brothers Life Sciences LP | director | Jun 2025 | Jun 5, 2026 | none |
| Baker Felix | director | Jun 2025 | Jun 5, 2026 | none |
| Baker Julian | director | Jun 2025 | Jun 5, 2026 | none |
| Cook Jennifer E. | director | Nov 2018 | Jun 5, 2026 | none |
| Flatley Jay T | director | Dec 2017 | Jun 5, 2026 | none |
| Klein Peter S | director | Mar 2018 | Jun 5, 2026 | none |
| Schenkein David P | director | Dec 2017 | Jun 5, 2026 | none |
| Van Hauwermeiren Timothy | director | Nov 2025 | Jun 5, 2026 | none |
Earlier names on the record25, newest filing first
Tessier-Lavigne Marc · director · last filing Jun 2025Sato Vicki L · director · last filing Jan 2025Harris Erik · director · last filing Jun 2024Cole Douglas G. · director · last filing Jun 2023Nelsen Robert · director · last filing Jun 2021Akdl, L.P. · 10% owner · last filing Feb 2021Bratton Douglas K · 10% owner · last filing Feb 2021Crestline Investors, Inc. · 10% owner · last filing Feb 2021Crestline Management, LP · 10% owner · last filing Feb 2021Crestline Si (Gp), L.P. · 10% owner · last filing Feb 2021Bratton Capital Inc. · 10% owner · last filing Dec 2020Bratton Capital Management, L.P. · 10% owner · last filing Dec 2020Neuro Line Partners LP · 10% owner · last filing Dec 2020Biogen Inc. · 10% owner · last filing Sep 2020Biogen Ma Inc. · 10% owner · last filing Sep 2020Arch Venture Fund Viii, L.P. · 10% owner · last filing Aug 2019Arch Venture Partners Viii, L.P. · 10% owner · last filing Aug 2019Arch Venture Partners Viii, LLC · 10% owner · last filing Aug 2019Bybee Clinton · 10% owner · last filing Aug 2019Crandell Keith · 10% owner · last filing Aug 2019Fmr LLC · 10% owner · last filing Apr 2018Fil Ltd · 10% owner · last filing Dec 2017Afeyan Noubar · 10% owner · last filing Dec 2017Flagship Ventures Fund V General Partner LLC · 10% owner · last filing Dec 2017Flagship Ventures Fund V, L.P. · 10% owner · last filing Dec 2017
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.